Rationale: Endothelial dysfunction and atherosclerosis are chronic inflammatory diseases characterized by activation of the innate and acquired immune system. Specialized protein receptors of the innate immune system recognize products of microorganisms and endogenous ligands such as nucleic acids. Toll-like receptor 3 (TLR3), for example, detects long double-stranded RNA and is abundantly expressed in endothelial cells. Whether innate immunity contributes to atherogenic mechanisms in endothelial cells is poorly understood.
set of pattern-recognition receptors is specialized for the immunorecognition of viral nucleic acids. For instance, long double-stranded RNA is detected by toll-like receptor (TLR) 3 and MDA5 (melanoma differentiation-associated gene 5) [2] [3] [4] [5] ; CpG motifs in DNA by TLR9 6 ; double-stranded DNA by DAI (DNA-dependent activator of interferon-regulatory factors) 7 and AIM2 (absent in melanoma 2) 8 ; single-stranded RNA containing certain sequence motifs by TLR7/8 9 ; or blunt-end double-stranded RNA containing a triphosphate at the 5Ј end by RIG-I (retinoic acid inducible gene I). 10, 11 Activation of these nucleic acid-detecting receptors induces a complex signaling cascade that results in the production of type I interferons and inflammation. 12 Endothelial function is essential for vascular integrity. The endothelium provides a barrier, regulates vascular tension, and is involved in angiogenesis and blood clotting. Local and systemic inflammation, however, can impair endothelial function and lead to cellular damage. 13 Damaged endothelial cells are renewed by healthy adjacent cells or by circulating progenitor cells. Both endothelial cells and endothelial progenitor cells (EPCs) are affected by inflammation, but to what extent they contribute to or are involved in inflammation is not yet known. 14 Here, we hypothesize that immunorecognition of doublestranded RNA by TLR3 influences endothelial integrity by inducing proinflammatory and proatherosclerotic mechanisms. We therefore studied the consequences of TLR3 stimulation on endothelial biology in mice, cultured endothelial cells, and EPCs.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals and Procedures
Eight-to 12-week-old C57BL/6J wild-type mice, TLR3-deficient mice (TLR3 Ϫ/Ϫ ; C57BL/6J genetic background), apolipoprotein E (ApoE)-deficient mice (ApoE Ϫ/Ϫ ; C57BL/6J genetic background), and ApoE Ϫ/Ϫ /TLR3 Ϫ/Ϫ mice (C57BL/6J genetic background) were used for the present study. For endothelial function tests, vascular reactive oxygen species (ROS) production analysis, and quantification of circulating and spleen-derived EPCs, wild-type and TLR3 Ϫ/Ϫ mice were injected intravenously with either 100 g of polyinosine polycytidylic acid (polyIC) suspended in 200 L of 0.9% NaCl solution or vehicle every 48 hours for 7 days. For investigation of atherosclerotic plaque development, 10-week-old ApoE Ϫ/Ϫ mice received a high-fat, cholesterol-rich diet that contained 21% fat, 19.5% casein, and 1.25% cholesterol for a total of 7 weeks and were injected intravenously with 100 g of polyIC or vehicle once in week 5 and then every other day during the last 2 weeks of diet. For endothelial function tests in TLR3-deficient ApoE Ϫ/Ϫ mice, ApoE
Ϫ/Ϫ and ApoE Ϫ/Ϫ /TLR3 ϩ/ϩ were fed the same high-fat, cholesterol-rich diet for 10 weeks. Aortic segments, spleen, blood, and carotid arteries were collected and processed immediately after the animals were euthanized.
Results
To investigate whether activation of the innate immune system and specifically TLR3 might be involved in the inflammatory vascular development of atherosclerosis, C57Bl/6J mice received an intravenous injection of vehicle or 100 g of polyIC, a synthetic long double-stranded RNA analog, every other day for 7 days. All mice showed no external signs of side effects; body weight, and food and water intake remained unchanged (data not shown). Because TLR3 is expressed in endothelial cells of human atherosclerotic plaques (Online Figure I) and endothelial dysfunction is an essential step of atherogenesis, we first assessed endothelial function in aortic segments of polyIC-and vehicle-treated mice using organ chamber experiments. Mice treated with vehicle displayed normal endothelium-dependent vasodilation, whereas TLR3 stimulation significantly impaired endothelial function ( Figure 1A ; maximum relaxation: vehicle 19.5Ϯ6.5% versus polyIC 45.8Ϯ7.7%, nϭ9 to 10). Endothelium-independent vasodilation ( Figure 1B ; nϭ9 to 10) and KCl-and phenylephrine-induced vasoconstriction (data not shown) were not affected by polyIC treatment. Another main mediator of vascular dysfunction is oxidative stress. Total vascular ROS production was therefore determined in aortic rings with L-012-enhanced chemiluminescence. PolyICtreated mice displayed significantly increased aortic ROS formation compared with controls ( Figure 1C ; vehicle 100Ϯ16.8% versus polyIC 189Ϯ26.8%, nϭ9 to 10). Increased ROS release can be caused by uncoupling of endothelial nitric oxide synthase 3, but endothelium-dependent vasodilation was reversed after the addition of N G -nitro-Larginine methyl ester, which indicates that no functionally relevant endothelial nitric oxide synthase 3 uncoupling was present in aortic tissue of these mice, and there was no difference between vehicle-and polyIC-treated mice (data not shown). Dihydroethidium-enhanced microscopy was used to study which cells were responsible for the increased ROS formation. Although both the intima and media showed increased radial production, the effect on endothelial cells was predominant (Online Figure II) .
To determine whether these biological effects of polyIC were indeed mediated by TLR3 stimulation, we analyzed TLR3-deficient (TLR3 Ϫ/Ϫ ) mice. TLR3 Ϫ/Ϫ mice were treated with polyIC every other day for 7 days, as described above. PolyIC had no effect on endothelium-dependent vasodilation ( Figure 1D ; nϭ10), endothelium-independent vasodilation ( Figure 1E; nϭ10) , or aortic ROS production ( Figure 1F; nϭ10) . Therefore, polyIC-induced endothelial dysfunction was a specific result of TLR3 stimulation. TLR2 and TLR4 have been associated with atherosclerosis development and known to affect endothelial cell biology. We therefore investigated TLR2/4 mRNA expression in aortic tissue from wild-type and TLR3
Ϫ/Ϫ mice to determine whether TLR3 deficiency affected TLR2/4 expression. Aortic Figure III) . Vascular damage develops in response to reoccurring endothelial lesions, and vascular health is therefore dependent on the regenerating capacity of the endothelium. Wild-type and TLR3
Ϫ/Ϫ mice were treated with vehicle or polyIC via intravenous injection every other day for a total of 10 days and were subjected to carotid artery injury on day 5. A 4-mm segment proximal to the bifurcation was denuded, and the rate of reendothelialization was assessed after staining with Evans blue. PolyIC treatment significantly inhibited reendothelialization in wild-type mice but had no effect in TLR3 Ϫ/Ϫ mice (Figures 2A and 2B ; wild-type: vehicle 27.5Ϯ3.0% versus polyIC 55.2Ϯ4.6%; TLR3 Ϫ/Ϫ : vehicle 28.8Ϯ2.7% versus polyIC 30.0Ϯ3.8%; nϭ5 to 7). Together, these data suggest that the immune response to TLR3 stimulation is associated with 3 fundamental endothelial mediators of atherosclerosis, namely, endothelial dysfunction, increased vascular ROS production, and reduced reendothelialization.
The effects of TLR3 stimulation on atherosclerotic plaque formation were therefore studied in ApoE Ϫ/Ϫ mice. Tenweek-old ApoE Ϫ/Ϫ mice received a high-fat, cholesterol-rich Figure 1 . PolyIC treatment impairs endothelial function but has no effect in TLR3 ؊/؊ mice. To determine whether TLR3 activation affects endothelial function in vivo, C57Bl6 mice received intravenous injections with vehicle or 100 g of polyIC every 48 hours for 7 days. A, Stimulation of TLR3 is associated with significantly impaired maximum endothelium-dependent vasodilation, whereas endothelium-independent vasodilation is not affected (B), which together indicates direct endothelial dysfunction. C, Total ROS production was also significantly increased in aortic segments of mice treated with polyIC, which highlights the increased vascular oxidative stress.
Next, TLR3
Ϫ/Ϫ mice were injected with vehicle or 100 g of polyIC as described above to examine whether the observed polyIC effects in wild-type mice were mediated via TLR3. Endothelium-dependent (D), endothelium-independent (E), and aortic ROS production (F) were not affected by polyIC treatment, which suggests a specific TLR3-induced effect in wild-type mice. *PϽ0.05. Max. indicates maximum.
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Figure 2. Activation of TLR3 hinders reendothelialization.
Endothelial repair is essential for vascular health and is reduced in patients with atherosclerosis. To test the cumulative effects of TLR3 stimulation on endothelial repair, wildtype and TLR3 Ϫ/Ϫ mice were injected with 100 g of polyIC every other day for 10 days and were subjected to carotid artery injury (4-mm electric denudation) on day 5. Reendothelialization was assessed by staining the denuded vessel wall with Evan blue. A, PolyIC treatment significantly impaired reendothelialization in wild-type but not TLR3 Ϫ/Ϫ mice, which suggests that TLR3 stimulation hinders endothelial repair. *PϽ0.05 compared with vehicle-treated wild-type mice. B, Representative carotid arteries. Black bars indicate the remaining denuded area.
diet for a total of 7 weeks and were injected intravenously with 100 g of polyIC or vehicle once in week 5 and then every other day during the last 2 weeks of diet. Similar to wild-type mice, endothelium-dependent vasodilation was significantly impaired by polyIC treatment in ApoE Ϫ/Ϫ mice ( Figure 3A ; maximum relaxation: vehicle 79.6Ϯ6.8% versus polyIC 50.6Ϯ5.7%, nϭ9), whereas endothelium-independent vasodilation was not affected ( Figure 3B ; nϭ9). Vascular ROS formation was also significantly increased by TLR3 stimulation ( Figure 3C ; vehicle 100Ϯ6.8% versus polyIC 180Ϯ37.9%, nϭ9). ApoE Ϫ/Ϫ mice that received vehicle developed only minimal atherosclerotic lesions above the valve leaflets ( Figure 3E; nϭ9) . In contrast, those mice treated with polyIC showed extensive plaques throughout the aortic arch (Figures 3D and 3E ; vehicle 29.6Ϯ4.0% versus polyIC 67.1Ϯ2.5%, nϭ9). Thus, TLR3 stimulation potentiates the development of atherosclerosis.
These results pose the question of whether endothelial cells, as direct targets, are able to detect and respond to TLR3 ligands. Consequently, we studied in vitro cytokine production of endothelial cells on stimulation with polyIC. Endothelial cells were incubated with 4 ng/mL polyIC or vehicle for 24 hours. The cytokine concentration in the supernatant medium was then analyzed by enzyme-linked immunosorbent assay. TLR3 activation increased the concentration of the proinflammatory cytokines interleukin-8 (IL-8) and interferon-␥-induced protein 10 (IP-10) but not that of IL-6 ( Figure 4A ; IL-8: vehicle 3248Ϯ251 pg/mL versus polyIC 5685Ϯ946 pg/mL; IP-10: vehicle 63Ϯ29 pg/mL versus polyIC 1222Ϯ835 pg/mL; IL-6: vehicle 867Ϯ70 pg/mL versus polyIC 1104Ϯ154 pg/mL; nϭ4 to 6). TLR3 expression in endothelial cells was also investigated after stimulation with polyIC. TLR3 activation led to a significant upregulation of TLR3 mRNA ( Figure 4B ; vehicle 1.0Ϯ0.1 2 Ϫ⌬⌬Ct versus polyIC 40.9Ϯ5. 4 2 Ϫ⌬⌬Ct , nϭ4). These results suggest that endothelial cells are activated by polyIC through TLR3.
Although inflammatory cytokines can be atherogenic, activation of TLR3 may also directly affect endothelial cell biology and thus support vascular lesion development. Our in vivo experiments showed increased ROS formation and reduced reendothelialization, both signs of endothelial dysfunction. We therefore investigated TLR3-induced ROS production in endothelial cells. Incubation with polyIC led to a significant increase in oxidative stress with L012-enhanced chemiluminescence ( Figure 4C ; vehicle 100% versus polyIC 133.4Ϯ4.5%, nϭ5) and as measured by 2Ј,7Ј-dichlorofluorescein fluorescence microscopy (Online Figure IV, A and B ; vehicle 1259Ϯ16.2 versus polyIC 1368Ϯ27.5 mean fluorescence intensity, nϭ9). Endothelial rejuvenation is dependent in part on proliferation, apoptosis, and migration of resident endothelial cells, and because TLR3 stimulation impaired in vivo reendothelialization, we sought to determine which Figure 4E ; vehicle 100Ϯ3.5% versus polyIC 136.2Ϯ6.9% of control, nϭ5), and impaired migration ( Figure 4F ; vehicle 29.5Ϯ10.1% versus polyIC 55.5Ϯ5.7% remaining cell-free area of total scratch area, nϭ5). To examine whether countering oxidative stress and proinflammatory cytokines can negate the negative effects of polyIC, we performed endothelial scratch assays. Preincubation of endothelial cells with the superoxide scavenger tiron had no effect on in vitro reendothelialization; however, preincubation with either an anti-IP-10 neutralizing antibody, an anti-IL-8 neutralizing antibody, or the combination of both completely antagonized the negative effects of polyIC ( Figure 4F; The endothelium is not a static tissue, and circulating EPCs contribute to the restoration of damaged endothelial cells. The rejuvenation capacity of these EPCs has been linked specifically to the number and function of available EPCs. We therefore studied EPC numbers in response to TLR3 stimulation in vivo. Wild-type, TLR3
Ϫ/Ϫ , and ApoE Ϫ/Ϫ mice were treated as detailed above, and blood was collected. Although polyIC treatment was associated with impaired endothelial function, TLR3 stimulation led to a significant increase of sca1/flk1-positive cells in peripheral blood of wild-type and ApoE Ϫ/Ϫ mice ( Figure 5A ; wild-type: vehicle 100Ϯ7.9% versus polyIC 165Ϯ14.4% of control; ApoE Ϫ/Ϫ : vehicle 104Ϯ3.3% versus polyIC 131Ϯ11.4% of control; nϭ9 to 10) but not of TLR3 Ϫ/Ϫ mice ( Figure 5A ; TLR3 Ϫ/Ϫ : 100Ϯ6.4% versus polyIC 105Ϯ3.3% of control, nϭ10). Not all EPCs circulate constantly, and the spleen is known as a functional reservoir for EPCs. Hence, the spleens of all mice were collected, and mononuclear cells were isolated by density gradient and cultured according to previously developed protocols. Stimulation of TLR3 significantly increased the number of spleen EPC colony-forming units in wild-type but not TLR3 Ϫ/Ϫ or ApoE Ϫ/Ϫ mice ( Figure 5B ; wild-type: vehicle 100Ϯ3.6% versus polyIC 317Ϯ91.8% of control; TLR3 Ϫ/Ϫ : 100Ϯ17.8% versus polyIC 94Ϯ10.3% of control; ApoE Ϫ/Ϫ : vehicle 98Ϯ23.7% versus polyIC 104Ϯ35.9% of control; nϭ9 to 10).
Although elevated numbers of circulating EPCs are generally associated with improved endothelial function, we found increased numbers of EPCs in polyIC-treated mice with dysfunctional endothelium. This may have been caused by a direct effect of TLR3 stimulation in EPCs. EPC function was thus tested in response to polyIC treatment in vitro. Produc- tion of ROS by early-outgrowth EPCs was significantly augmented by TLR3 activation compared with controls (Figure 6A ; vehicle 100Ϯ15.0% versus polyIC 294Ϯ49.1% of control, nϭ8). Incubation with polyIC also significantly increased apoptosis ( Figure 6B ; vehicle 100Ϯ6.1% versus polyIC 135Ϯ18% of control, nϭ8) and impaired migration ( Figure 6C ; Figure 8B) or KCl-or phenylephrine-induced vasoconstriction (data not shown) was noted. These results suggest that TLR3 is involved in atherogenesis independent of synthetic stimulation.
Discussion
The main contenders in vascular inflammation have been identified, but the rules by which they act remain unclear. Recent evidence from the literature suggests that vascular inflammation is not a mere macrophage crusade but rather an elaborate campaign that involves both resident smooth muscle and endothelial cells, as well as circulating cells. Here, we show that endothelial cells are immune competent and can actively participate in innate immunity. Stimulation of the specific pattern-recognition receptor TLR3 on endothelial cells induced inflammatory and atherogenic mechanisms in endothelial cells in vitro and was associated with damaging Endothelial health is closely related to the number and function of available endothelial regenerating cells. EPC numbers were determined in wild-type, TLR3 Ϫ/Ϫ , and ApoE Ϫ/Ϫ mice treated with either vehicle or polyIC. A, Surprisingly, the number of sca1/flk1-positive particles (circulating angiogenic cells, a subtype of EPCs) was increased significantly in wild-type and ApoE Ϫ/Ϫ mice treated with polyIC compared with controls. PolyIC injection had no effect on the number of circulating angiogenic cells in TLR3 Ϫ/Ϫ mice (A). The spleen represents a reservoir for EPCs, and early-outgrowth EPCs can be cultured from isolated spleen-derived mononuclear cells. B, The number of EPC colony-forming units (CFU) was increased significantly in wild-type but not TLR3 Ϫ/Ϫ or ApoE Ϫ/Ϫ mice after TLR3 stimulation. *PϽ0.05 compared with vehicle-treated wild-type mice;°P Ͻ0.05 compared with vehicle-treated ApoE Ϫ/Ϫ mice.
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A B C processes in vivo. The results of the present study support a concept in which a vicious circle of cellular damage, endogenous RNA release, and TLR3 activation contributes to the development of endothelial dysfunction.
We found an increased production of the proinflammatory cytokines IP-10 and IL-8 by endothelial cells on exposure to the TLR3 stimulus polyIC. IP-10, also known as chemokine (C-X-C motif) ligand 10 (CXCL10), is a proinflammatory cytokine secreted by monocytes, endothelial cells, and fibroblasts in response to exogenous type I interferons 15 or TLR ligands that induce type I interferon, including TLR3. IP-10 binds to CXCR3 and has been associated directly with the development of atherosclerosis. Heller et al 16 even demonstrated that formation of atherosclerotic plaques is significantly inhibited in ApoE Ϫ/Ϫ /IP-10 Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ control mice. IP-10 on endothelial cells is involved in the transendothelial migration/recruitment of leukocytes into the vascular wall. 17 IL-8 (CXCL8) is produced by endothelial cells, smooth muscle cells, and macrophages in the vessel wall. It binds to the G-protein-coupled serpentine receptors CXCR1 and CXCR2 and has chemoattractant and mitogenic effects. Expression of IL-8 is amplified in atherosclerotic plaques, and circulating IL-8 has been proposed as a biomarker for coronary artery disease. 18 Thus, increased IP-10 and IL-8 secretion through TLR3 stimulation could have detrimental effects on vascular health. Not only inflammation induced by cytokines but also direct effects of TLR3 activation in endothelial cells can contribute to atherogenesis. We have shown that endothelial production of ROS is increased by TLR3 stimulation. The rapid formation of ROS by immune cells, as in the oxidative burst of neutrophils and macrophages, is an important mechanism of encountering pathogens. ROS release can lead to cellular dysfunction and damage, and it is well established that ROS contribute to all stages of endothelial dysfunction and atherosclerosis development. The TLR3-stimulated ROS formation by endothelial cells in the present study is consistent with TLR3-induced ROS induction in neutrophils 19 and macrophages. 20 Additionally, we found increased apoptosis and reduced proliferation of endothelial cells in response to polyIC. Together, these polyIC effects on endothelial cells could be responsible for the compromised endothelial function and regenerating capacity in vivo, as reflected by the impaired endothelium-dependent vasodilation and impaired reendothelialization in the present experiments. A different aspect of endothelial function, namely, hemostasis balance, in response to polyIC treatment has been studied by Shibamiya and colleagues. 21 In their model, polyIC upregulated tissue factor and downregulated thrombomodulin expression by endothelial cells. In vivo, polyIC elevated D-dimer levels, which indicates increased coagulation and fibrinolysis. 21 This fur- ther corroborates the critical role of TLR3 in endothelial cell function.
Although polyIC treatment is associated with an increased number of circulating EPCs, reendothelialization is reduced. This seemingly contradictory finding could be explained by 2 mechanisms. First, TLR3 stimulation could directly impair EPC function. We found elevated apoptosis and increased ROS formation by EPCs in response to polyIC. Second, the TLR3-induced increase in EPC numbers may be the consequence of severe endothelial damage, and EPC numbers may simply not be sufficient to keep up with the increased repair demand.
The primary function of TLR3 is thought to be the detection of viral RNA. Although there is evidence of viral products in atherosclerotic plaques, it seems unlikely that recurrent or chronic viral infections are a major contributor to atherosclerotic development. Recent studies demonstrated that short RNA sequences similar to those used for RNA interference (small interfering RNA, or siRNA) are sufficient to stimulate TLR3. 22 Although small interfering RNA has no full TLR3 ligand activity (unpublished data) and may have additional effects on microRNA (RNA-induced silencing complex consumption), small interfering RNA is not comparable to the well-established TLR3 ligand polyIC used in the present study; still, the observation by Cho et al 22a that small interfering RNA inhibits neovascularization through activation of TLR3 is well in agreement with our findings. The cellular damage that leads to this endogenous TLR3 ligand release is found in all stages of atherosclerosis development and may therefore be of significant impact.
Other TLRs have also been associated with the development of atherosclerosis. TLR4, a transmembrane receptor for lipopolysaccharide, for example, is expressed in low levels in healthy arterial walls but is upregulated in atherosclerotic plaques. Furthermore, it is concentrated in the shoulder region, where a plaque is most likely to rupture. 23 TLR4 stimulation induces production of proinflammatory cytokines and adhesion molecules by endothelial cells and mediates the release of matrix metalloproteinase by macrophages. 24 Interestingly, mice deficient in TLR4 and MyD88 (myeloid differentiation factor 88) show reduced atherosclerosis development. 25 TLR2 is also expressed in human atherosclerotic plaques. Stimulation of TLR2 significantly enhances neointima formation and promotes atherosclerotic plaque development. 26 In contrast to TLR3, these receptors are specialized in detecting products of bacterial membranes, which, although sometimes found in atherosclerotic plaques, are ubiquitously present. Endogenous TLR3 ligands, however, are released constantly during cellular damage and could be important for all stages of atherogenesis.
Together, the present data provide novel insights into the functional role of innate immunity in endothelial biology and support the potential involvement of TLR3 in the pathomechanisms of atherosclerosis. TLR3 is expressed by endothelial cells, and endogenous RNA ligands are readily available through continuous cellular damage. Because TLR3 severely compromises endothelial function and promotes atherosclerotic plaque development, we propose that inhibition of TLR3 function may diminish TLR3-dependent endothelial dysfunction and thus provide a potentially novel target for the treatment of atherosclerosis.
